Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.
about
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand.The translation factor eIF5A and human cancer.Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samplesRoles of eukaryotic initiation factor 5A2 in human cancer.EIF5A2 is a novel chemoresistance gene in breast cancer.Eukaryotic translation initiation factors and cancer.Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2.Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
P2860
Q34137202-29F90C95-FD32-4B69-B82B-6A19E1CFCB4FQ35051469-24A24865-A197-4B6F-8FD8-A4203B9177E3Q35982594-ADFB784F-ACB9-4931-A729-1065FA7B66B0Q36519353-413A9A4B-1A21-4492-BC81-85BC19CE034AQ37520334-2012C14D-EFE9-499F-85DE-77B9589AB775Q38163977-DB82CB80-E064-4AEB-9866-A509686B4655Q39014521-34C20CA8-A11F-41BB-8790-DFB58E74B6E6Q39400409-1952BA49-6A2D-4822-BFAE-827892A1F981Q39408668-E4C9C87C-1B9B-4973-AF73-0AFF5021C623Q47422423-BEFB2E1A-23F0-466C-A7F8-CF41D738FB55Q49335206-F1EDFA68-22CA-4D82-B6AC-A632BB4F92CBQ54254509-F4447836-2980-4A86-ADE5-00882673DCADQ58800121-A3E38A8A-83A1-40F3-B41E-28BBC62495B2
P2860
Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@ast
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@en
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@nl
type
label
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@ast
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@en
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@nl
prefLabel
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@ast
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@en
Overexpression of EIF-5A2 pred ...... lial carcinoma of the bladder.
@nl
P2093
P2860
P1433
P1476
Overexpression of EIF-5A2 pred ...... elial carcinoma of the bladder
@en
P2093
Hsiang-Fu Kung
Hui-Lan Rao
Jun-Hang Luo
Wen-Feng Hua
Yi-Ji Liao
Yi-Xin Zeng
P2860
P304
P356
10.1111/J.1349-7006.2009.01126.X
P577
2009-02-26T00:00:00Z